Significant predictors of medically diagnosed chronic obstructive pulmonary disease in patients with preserved ratio impaired spirometry: a 3-year cohort study

被引:53
作者
Park, Hye Jung [1 ]
Byun, Min Kwang [1 ]
Rhee, Chin Kook [2 ]
Kim, Kyungjoo [2 ]
Kim, Hyung Jung [1 ]
Yoo, Kwang-Ha [3 ]
机构
[1] Yonsei Univ, Gangnam Severance Hosp, Dept Internal Med, Coll Med, 211 Eonju Ro Gangnam Gu, Seoul 06273, South Korea
[2] Catholic Univ Korea, Div Pulm Allergy & Crit Care Med, Coll Med, Dept Internal Med,Seoul St Marys Hosp, Seoul, South Korea
[3] Konkuk Univ, Dept Internal Med, Sch Med, Seoul, South Korea
来源
RESPIRATORY RESEARCH | 2018年 / 19卷
关键词
Chronic obstructive pulmonary disorder; Prognosis; Spirometry; HEALTH-CARE USE; LUNG-DISEASE; NUTRITION EXAMINATION; NATIONAL-HEALTH; RISK-FACTORS; SMOKERS; PREVALENCE; MORTALITY; COPD; ASSOCIATION;
D O I
10.1186/s12931-018-0896-7
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Preserved ratio impaired spirometry (PRISm) is an incompletely understood respiratory condition. We investigated the incidence and significant predictive factors of chronic obstructive pulmonary disease (COPD) in PRISm patients. Methods: From 11,922 subjects registered in the Korea National Health and Nutrition Examination Survey, never or light smokers, young subjects, and those already medically diagnosed with COPD (defined by ICD-10 code and prescribed medication) were excluded. The 2666 remaining subjects were categorized into PRISm (normal forced expiratory volume in the first second [FEV1]/force vital capacity [FVC] [>= 0.7] and low FEV1 (< 80%); n = 313); normal (n = 1666); and unrevealed COPD groups (FEV1/FVC ratio < 0.7; n = 687). These groups were compared using matched Health Insurance Review and Assessment Service data over a 3-year follow-up. Results: COPD incidence in PRISm patients (17/1000 person-year [PY]) was higher than that in normal subjects (4.3/1000 PY; P < 0.001), but lower than that in unrevealed COPD patients (45/1000 PY; P < 0.001). PRISm patients visited hospitals, took COPD medication, and incurred hospitalization costs more frequently than normal subjects, but less frequently than unrevealed COPD patients. In the overall sample, age, FVC, FEV1, dyspnea, and wheezing were significant predictors of COPD, but in PRISm patients, only age (OR, 1.14; P = 0.002) and wheezing (OR, 4.56; P = 0.04) were significant predictors. Conclusion: PRISm patients are likely to develop COPD, and should be monitored carefully, especially older patients and those with wheezing, regardless of lung function.
引用
收藏
页数:11
相关论文
共 35 条
[21]   Chronic obstructive pulmonary disease in non-smokers [J].
Salvi, Sundeep S. ;
Barnes, Peter J. .
LANCET, 2009, 374 (9691) :733-743
[22]  
Sim YS, 2017, TUBERC RESPIR DIS, V80, P105, DOI 10.4046/trd.2017.80.2.105
[23]  
Smith O O, 2001, Paediatr Respir Rev, V2, P178, DOI 10.1053/prrv.2000.0127
[24]   Spirometric variability in smokers: transitions in COPD diagnosis in a five-year longitudinal study [J].
Sood, Akshay ;
Petersen, Hans ;
Qualls, Clifford ;
Meek, Paula M. ;
Vazquez-Guillamet, Rodrigo ;
Celli, Bartolome R. ;
Tesfaigzi, Yohannes .
RESPIRATORY RESEARCH, 2016, 17
[25]   Spirometrically-defined restrictive ventilatory defect: population variability and individual determinants [J].
Soriano, Joan B. ;
Miravitlles, Marc ;
Garcia-Rio, Francisco ;
Munoz, Luis ;
Sanchez, Guadalupe ;
Sobradillo, Victor ;
Duran, Enric ;
Guerrero, Dolores ;
Ancochea, Julio .
PRIMARY CARE RESPIRATORY JOURNAL, 2012, 21 (02) :187-193
[26]   Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study [J].
Tan, W. C. ;
Bourbeau, J. ;
Hernandez, P. ;
Chapman, K. R. ;
Cowie, R. ;
FitzGerald, J. M. ;
Marciniuk, D. D. ;
Maltais, F. ;
Buist, A. S. ;
O'Donnell, D. E. ;
Sin, D. D. ;
Aaron, S. D. .
THORAX, 2014, 69 (08) :709-717
[27]   Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study [J].
Terzikhan, Natalie ;
Verhamme, Katia M. C. ;
Hofman, Albert ;
Stricker, Bruno H. ;
Brusselle, Guy G. ;
Lahousse, Lies .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2016, 31 (08) :785-792
[28]   Prevalence, Incidence, and Lifetime Risk for the Development of COPD in the Elderly The Rotterdam Study [J].
van Durme, Yannick M. T. A. ;
Verhamme, Katia M. C. ;
Stijnen, Theo ;
van Rooij, Frank J. A. ;
Van Pottelberge, Geert R. ;
Hofman, Albert ;
Joos, Guy F. ;
Stricker, Bruno H. Ch. ;
Brusselle, Guy G. .
CHEST, 2009, 135 (02) :368-377
[29]   Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary [J].
Vogelmeier, Claus F. ;
Criner, Gerard J. ;
Martinez, Fernando J. ;
Anzueto, Antonio ;
Barnes, Peter J. ;
Bourbeau, Jean ;
Celli, Bartotome R. ;
Chen, Rongchang ;
Decramer, Marc ;
Fabbri, Leonardo M. ;
Frith, Peter ;
Halpin, David M. G. ;
Varela, M. Victorina Lopez ;
Nishimura, Masaharu ;
Roche, Nicolas ;
Rodriguez-Roisin, Roberto ;
Sin, Don D. ;
Singh, Dave ;
Stockley, Robert ;
Vestbo, Jorgen ;
Wedzicha, Jadwiga A. ;
Agusti, Y. Alvar .
ARCHIVOS DE BRONCONEUMOLOGIA, 2017, 53 (03) :128-149
[30]   Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene [J].
Wan, Emily S. ;
Castaldi, Peter J. ;
Cho, Michael H. ;
Hokanson, John E. ;
Regan, Elizabeth A. ;
Make, Barry J. ;
Beaty, Terri H. ;
Han, MeiLan K. ;
Curtis, Jeffrey L. ;
Curran-Everett, Douglas ;
Lynch, David A. ;
DeMeo, Dawn L. ;
Crapo, James D. ;
Silverman, Edwin K. .
RESPIRATORY RESEARCH, 2014, 15